TECH Bio-Techne Corporation
$72.61
Bio-Techne Corporation (TECH) is expected to report earnings on November 2, 2026, before the market open. The consensus earnings estimate is $0.40 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.7% since its last earnings release on August 12, 2026.
Bio-Techne Beat Consensus Estimates
Wednesday, August 12, 2026 · 6:30 AM ET
Earnings Date
1st Quarter, Sep 2026
Nov 2
Monday · 6:30 AM ET
Earnings Whisper
-
vs $0.40
Rev est $293.46M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$72.34
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Bio-Techne Corporation
Bio-Techne Corp is engaged in the laboratory research, translational research and diagnostic manufacturing. Its brands include R&D Systems, Novus Biologicals, Tocris, ProteinSimple, and BiosPacific.
Sector
Healthcare
Industry
Medical Instruments/Supply
Held By 12 ETFs, by dollar flow
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- BMED iShares Health Innovation Active ETF
- BMED iShares Health Innovation Active ETF
- BBH VanEck Biotech ETF
- BBH VanEck Biotech ETF
Charts powered in part by Lightweight Charts™ by TradingView.